Literature DB >> 27142900

Adjunctive Hyperbaric Oxygen Therapy promotes successful healing in patients with refractory Crohn's disease.

Marley Ribeiro Feitosa1, Omar Féres Filho2, Camila Mussolin Tamaki3, Camila Perazzoli1, Mário Vinícius Angelete Alvarez Bernardes1, Rogério Serafim Parra1, José Joaquim Ribeiro da Rocha1, Omar Féres1.   

Abstract

PURPOSE: To investigate de adjunctive effect of Hyperbaric Oxygen Therapy in a group of patients with refractory Crohn's disease.
METHODS: A total of 29 subjects with refractory Crohn's disease were submitted to daily sessions of Hyperbaric Oxygen Therapy, in a 2800 Sechrist Monoplace Hyperbaric Chamber (Sechrist, USA) pressurized to 2.4 ATA. Each session lasted 2 hours. The endpoint was closure of enterocutaneous fistulas and complete healing of Pyoderma Gangrenosum and perineal Crohn's disease.
RESULTS: A total of 829 HBOT sessions were performed and no complications were noted. Overall success rate was 76% (22 cases). Pyoderma Gangrenosum and enterocutaneous fistulas had the highest successful healing rates (100% and 91%, respectively). Perineal Crohn's disease healing rate was 65%.
CONCLUSION: Adjunctive Hyperbaric Oxygen Therapy promoted satisfactory healing in a group of patients with refractory Crohn's disease.

Entities:  

Mesh:

Year:  2016        PMID: 27142900     DOI: 10.1590/S0102-86502016001300005

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  8 in total

1.  Hyperbaric oxygen therapy for Crohn's disease complications: What do we know?

Authors:  Rogério Serafim Parra; Marley Ribeiro Feitosa; Omar Féres
Journal:  United European Gastroenterol J       Date:  2020-07-09       Impact factor: 4.623

2.  Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome.

Authors:  Débora Gouveia; Mariana Chichorro; Ana Cardoso; Carla Carvalho; Cátia Silva; Tiago Coelho; Isabel Dias; António Ferreira; Ângela Martins
Journal:  Vet Sci       Date:  2022-01-18

Review 3.  The role of hyperbaric oxygen therapy in inflammatory bowel disease: a narrative review.

Authors:  Xin Wu; Tian-Yu Liang; Zhong Wang; Gang Chen
Journal:  Med Gas Res       Date:  2021 Apr-Jun

4.  Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease.

Authors:  Corine A Lansdorp; Krisztina B Gecse; Christianne J Buskens; Mark Löwenberg; Jaap Stoker; Willem A Bemelman; Geert R A M D'Haens; Rob A van Hulst
Journal:  Aliment Pharmacol Ther       Date:  2020-12-16       Impact factor: 8.171

5.  Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn's Disease: An Observational Study.

Authors:  Marley R Feitosa; Rogério S Parra; Vanessa F Machado; Gustavo N Vilar; Jussara C Aquino; José J R Rocha; Paulo G Kotze; Omar Féres
Journal:  Gastroenterol Res Pract       Date:  2021-04-26       Impact factor: 2.260

6.  Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT-TOPIC trial after 1-year follow-up.

Authors:  Corine A Lansdorp; Christianne J Buskens; Krisztina B Gecse; Mark Löwenberg; Jaap Stoker; Willem A Bemelman; Geert R A M D'Haens; Rob A van Hulst
Journal:  United European Gastroenterol J       Date:  2022-02-10       Impact factor: 4.623

Review 7.  Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.

Authors:  A Hillary Steinhart; Remo Panaccione; Laura Targownik; Brian Bressler; Reena Khanna; John K Marshall; Waqqas Afif; Charles N Bernstein; Alain Bitton; Mark Borgaonkar; Usha Chauhan; Brendan Halloran; Jennifer Jones; Erin Kennedy; Grigorios I Leontiadis; Edward V Loftus; Jonathan Meddings; Paul Moayyedi; Sanjay Murthy; Sophie Plamondon; Greg Rosenfeld; David Schwartz; Cynthia H Seow; Chadwick Williams
Journal:  J Can Assoc Gastroenterol       Date:  2018-09-14

8.  Hyperbaric oxygen therapy for the treatment of rectovaginal fistulas in patients with Crohn's disease: results of the HOT-REVA pilot study.

Authors:  C A Lansdorp; C J Buskens; K B Gecse; G R A M D'Haens; R A van Hulst
Journal:  BJS Open       Date:  2021-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.